Y Gruel
Overview
Explore the profile of Y Gruel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
722
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hardy M, Lecompte T, Douxfils J, Lessire S, Dogne J, Chatelain B, et al.
Thromb J
. 2020 Sep;
18:17.
PMID: 32922211
Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of thromboembolic events has been reported despite thromboprophylaxis, raising the question...
2.
Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet J, et al.
Anaesth Crit Care Pain Med
. 2018 Oct;
38(3):289-302.
PMID: 30366119
The French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Haemostasis and Thrombosis (GFHT) in collaboration with the French Society of Anaesthesia and Intensive Care Medicine...
3.
Tromeur C, Le Mao R, Jego P, El-Kouri D, Gruel Y, Pan-Petesch B, et al.
Rev Mal Respir
. 2018 Oct;
36(2):219-226.
PMID: 30318429
Objective: To demonstrate an association between the risk of VTE in young women with hormonal exposure (pregnancy or oral contraceptive use) and the presence of a previous episode of VTE...
4.
Touze E, Gruel Y, Gouin-Thibault I, de Maistre E, Susen S, Sie P, et al.
Eur J Neurol
. 2018 Jan;
25(5):747-e52.
PMID: 29360254
Background And Purpose: Whereas intravenous thrombolysis (IVT) is allowed for acute ischaemic stroke in patients on vitamin K antagonists with international normalized ratio ≤1.7, there are no similar recommendations for...
5.
Negrier C, Ducloy-Bouthors A, Piriou V, de Maistre E, Stieltjes N, Borel-Derlon A, et al.
Vox Sang
. 2017 Dec;
113(2):120-127.
PMID: 29238971
Background And Objectives: A postauthorization safety study was performed between 2009 and 2012 to describe the use of Clottafact in acquired fibrinogen deficiency in real-life medical practice in France. Materials...
6.
Perez T, Valentin J, Saliba E, Gruel Y
Arch Pediatr
. 2017 Sep;
24(9S):9S28-9S34.
PMID: 28867034
All biological risk factors that have been previously identified to increase the risk of thrombosis in adults, have also been studied in neonates with arterial Ischemic Stroke (NAIS), but most...
7.
Liesner R, Abashidze M, Aleinikova O, Altisent C, Belletrutti M, Borel-Derlon A, et al.
Haemophilia
. 2017 Aug;
24(2):211-220.
PMID: 28815880
Introduction: Nuwiq (Human-cl rhFVIII) is a fourth generation recombinant FVIII, produced in a human cell line, without chemical modification or protein fusion. No inhibitors developed in studies with Nuwiq in...
8.
Kizlik-Masson C, Vayne C, McKenzie S, Poupon A, Zhou Y, Champier G, et al.
J Thromb Haemost
. 2017 Aug;
15(10):2065-2075.
PMID: 28771917
Summary: Background The diagnosis of heparin-induced thrombocytopenia (HIT) is based on clinical and biological criteria, but a standard is lacking for laboratory assays. Moreover, no humanized HIT antibody is available...
9.
Auvin S, Baud O, Biran V, Chabernaud J, Chabrier S, Cneude F, et al.
Arch Pediatr
. 2016 Dec;
24(2):180-188.
PMID: 28011082
Neonatal arterial ischemic stroke (NAIS) is a rare event that occurs in approximately one in 5000 term or close-to-term infants. Most affected infants will present with seizures. Although a well-recognized...
10.
Pouplard C, Vayne C, Berthomet C, Guery E, Delahousse B, Gruel Y
Int J Lab Hematol
. 2016 Dec;
39(3):e60-e63.
PMID: 28004514
No abstract available.